Thoracic Cancer Research - Penn State Cancer Institute
Thoracic Cancer Research
Research into thoracic cancer at Penn State Cancer Institute is conducted by our dedicated thoracic cancer team. See current clinical trials and members of that team here.
Clinical Trials
Repository of Lung Cancer Diagnostic Procedure Images
Piloting a Virtual Navigation (VN) System for Bronchoscopic Tissue Sampling
Phase II Study of Osimertinib in Advanced NSCLC Patients with Exon 20 Mutations in EGFR
The COVID-19 and Cancer Consortium (CCC19) Registry
NRG-LU007 Randomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR trial
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination With Immuno-Oncology Agents in Subjects With Unresectable Advanced or Metastatic Solid Tumors
NRG-LU008: Phase III Prospective Randomized Trial Of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed By Concurrent Mediastinal Chemoradiation For Locally Advanced Non-Small Cell Lung Cancer
General Protocol for the Acquisition of Whole Blood for the Detection and Characterization of Circulating Tumor Cells and/or Tumor Specific Immunity/Immune Cell Activation for any Malignancy at any Stage of Disease
Oncogenic Mutations/Gene Rearrangements in Patients with Advanced Adenocarcinoma Lung
One Time Tissue and Blood Collection from Patients with Lung Cancer at Risk for Developing Lung Cancer
Disease Team Members
| First Name | Last Name | Title | Role | ||
|---|---|---|---|---|---|
 |
Chandra | Belani | MD | ||
 |
Mitchell | Machtay | MD | ||
 |
Michael F. | Reed | MD | ||
 |
Matthew D. | Taylor | MD | ||
 |
Jennifer | Toth | MD | ||
 |
Leonard | Tuanquin | MD |
Research into thoracic cancer at Penn State Cancer Institute is conducted by our dedicated thoracic cancer team. See current clinical trials and members of that team here.
Repository of Lung Cancer Diagnostic Procedure Images
Piloting a Virtual Navigation (VN) System for Bronchoscopic Tissue Sampling
Phase II Study of Osimertinib in Advanced NSCLC Patients with Exon 20 Mutations in EGFR
The COVID-19 and Cancer Consortium (CCC19) Registry
NRG-LU007 Randomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR trial
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination With Immuno-Oncology Agents in Subjects With Unresectable Advanced or Metastatic Solid Tumors
NRG-LU008: Phase III Prospective Randomized Trial Of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed By Concurrent Mediastinal Chemoradiation For Locally Advanced Non-Small Cell Lung Cancer
General Protocol for the Acquisition of Whole Blood for the Detection and Characterization of Circulating Tumor Cells and/or Tumor Specific Immunity/Immune Cell Activation for any Malignancy at any Stage of Disease
Oncogenic Mutations/Gene Rearrangements in Patients with Advanced Adenocarcinoma Lung
One Time Tissue and Blood Collection from Patients with Lung Cancer at Risk for Developing Lung Cancer
| First Name | Last Name | Title | Role | ||
|---|---|---|---|---|---|
|
Chandra | Belani | MD | ||
|
Mitchell | Machtay | MD | ||
|
Michael F. | Reed | MD | ||
|
Matthew D. | Taylor | MD | ||
|
Jennifer | Toth | MD | ||
|
Leonard | Tuanquin | MD |